PARP1 and neuroblastoma: In this study, we observed, in pre-clinical models of neuroblastoma, that the third generation PARP-1 inhibitors, rucaparib and olaparib, significantly enhanced the efficacy of ionising radiation, in the form of external beam X-rays or 131I-MIBG.